Molecular dispersion composition with enhanced bioavailability
US6632455B2 · kind B2 · utility
12Cited by
41References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 1998 |
| Grant date | Oct 14, 2003 |
| Priority date | — |
| Expiry date | Dec 17, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/146
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A molecular dispersion composition is disclosed. The molecular dispersion comprises a compound of the formula: molecularly dispersed in a polymer matrix. Also disclosed are solid dosage forms, e.g., tablets and capsules, containing these molecular dispersions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.